within Pharmacolibrary.Drugs.ATC.J;

model J01XX01_1
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00015333333333333334,
    adminDuration  = 600,
    adminMass      = 4000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0136,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.009699999999999999,
    k12             = 23.1,
    k21             = 23.1
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01XX01_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Fosfomycin is a broad-spectrum antibiotic primarily used to treat uncomplicated urinary tract infections. It works by inhibiting bacterial cell wall synthesis and is effective against both Gram-positive and Gram-negative bacteria. Fosfomycin (with ATC code J01XX01) is approved for clinical use and remains in use today, particularly for treating urinary tract infections.</p><h4>Pharmacokinetics</h4><p>Intravenous administration to healthy adults; pharmacokinetics after single intravenous infusion.</p><h4>References</h4><ol><li><p>Pipitone, G, et al., &amp; Iaria, C (2023). Intravenous Fosfomycin for Systemic Multidrug-Resistant . <i>Antibiotics (Basel, Switzerland)</i> 12(12) –. DOI:<a href=\"https://doi.org/10.3390/antibiotics12121653\">10.3390/antibiotics12121653</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38136687/\">https://pubmed.ncbi.nlm.nih.gov/38136687</a></p></li><li><p>Kirby, WM (1977). Pharmacokinetics of fosfomycin. <i>Chemotherapy</i> 23 Suppl 1 141–151. DOI:<a href=\"https://doi.org/10.1159/000222040\">10.1159/000222040</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/832510/\">https://pubmed.ncbi.nlm.nih.gov/832510</a></p></li><li><p>Jumpertz, M, et al., &amp; Cassir, N (2022). Subcutaneously administered antibiotics: a review. <i>The Journal of antimicrobial chemotherapy</i> 78(1) 1–7. DOI:<a href=\"https://doi.org/10.1093/jac/dkac383\">10.1093/jac/dkac383</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36374566/\">https://pubmed.ncbi.nlm.nih.gov/36374566</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01XX01_1;
